Teva, Watson delays yield Tetracycline shortage; Regulatory science center set at USC;

> Tetracycline tablets have found their way to the FDA drug shortages list; both Teva ($TEVA) and Watson cite manufacturing delays and neither can say when the capsules will be available. Listing

> The International Center for Regulatory Science has been established at the University of Southern California's School of Pharmacy. Release

> Applied DNA Sciences ($APDN), a company that tailors gene-splicing technology to industrial applications, is segmenting and shuffling plant DNA and adding it to printing ink as a tag that can be sensed with a handheld scanner for anticounterfeiting. Story

> Corning Life Sciences ($GLW) has opened a manufacturing and distribution facility in China's Yangtze River Delta. News

> The Shanghai Food and Drug Administration teamed with police to bust a counterfeiting ring making 66 fakes, including erectile dysfunction drugs Viagra and Xilishi. More

> Instrument supplier Analytik says the FDA has bought two LabSpec systems for counterfeit drug analysis. Article

> Aesica Pharmaceuticals, Piramal Healthcare and Shasun Pharma Solutions are among Northumberland, U.K., companies that will enjoy a $27 million government grant package intended to create or protect nearly 200 jobs. Story

> Contract manufacturer Custom Processing Services will dedicate its newly built, 42,000-square-foot manufacturing facility tomorrow at Exeter Industrial Park in Pennsylvania. News

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.